Cloning, expression and purification DRB4 (1-355) (hereafter DRB4) was amplified from pGEX6p-DRB4 containing full length DRB4. The amplified PCR fragment was double digested with restriction enzymes, NdeI and XhoI and ligated into pET-30a using standard molecular biology techniques. The truncated fragments of DRB4; DRB4 (1-153) (hereafter DRB4D1D2), DRB4 (1-75) (hereafter: DRB4D1), DRB4 (80-153) (hereafter: DRB4D2), DRB4 (154-355) (hereafter: DRB4C), DRB4 (294-355) (hereafter: DRB4Cc), DRB4 (72-81 connected to 4-71) (hereafter: DRB4LD1) and DRB4 (72-153) (hereafter: DRB4LD2) were also cloned into pET-30a in a similar way. Domain swapped construct, DRB4D2D1 was prepared by two-step PCR, wherein the part of linker sequence was introduced to dsRBD1 and dsRBD2 at their N-terminus and C-terminus, respectively and PCR amplified separately. The amplified fragments were annealed with overlapping linker region and PCR amplified to generate DRB4D2D1. DRB4D1D2 containing native cysteines at 38 th and 43 rd residues were mutated to alanine to generate cysteine-less DRB4D1D2. Several constructs with single surface exposed cysteine were generated in DRB4D1D2 at Q8, A24, A69, N85, A102 and M138 amino acid positions. Samples with 25 µM concentration (in 50 mM potassium phosphate buffer (pH 7.2), 50 mM NaCl and 50 mM Na 2 SO 4 )
Domain swapped construct, DRB4D2D1 was prepared by two-step PCR, wherein the part of linker sequence was introduced to dsRBD1 and dsRBD2 at their N-terminus and C-terminus, respectively and PCR amplified separately. The amplified fragments were annealed with overlapping linker region and PCR amplified to generate DRB4D2D1.
DRB4D1D2 containing native cysteines at 38
th and 43 rd residues were mutated to alanine to generate cysteine-less DRB4D1D2. Several constructs with single surface exposed cysteine were generated in DRB4D1D2 at Q8, A24, A69, N85, A102 and M138 amino acid positions. Samples with 25 µM concentration (in 50 mM potassium phosphate buffer (pH 7.2), 50 mM NaCl and 50 mM Na 2 SO 4 )
were incubated overnight with 5 molar excess (2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl) methyl methanesulfonothioate (MTSL) at 4°C. Further, the samples were centrifuged at 10,000 rpm, 4°C for 10 min to remove aggregated protein. Later, samples were washed multiple times to remove unreacted MTSL from the solution and concentrated to 250 µM. Diamagnetic samples were prepared by addition of 5 molar excess ascorbic acid to the paramagnetic sample.
Seven active site mutations were created for DRB4D1D2, which includes five double mutants (K6A/Q10A; L56A/K57A; K84A/Q88A; K133A/K134A and H32A/K133A) and two single mutants (H32A and H110A). Likewise, three active site double mutants (L56A/K57A; K133A/K134A and H32A/K133A)
were generated for DRB4. Site directed mutagenesis was performed by sequentially mutating the required amino acids to alanine by whole plasmid PCR with primers containing desired nucleotide mismatch.
All constructs followed previously optimized expression and purification conditions established for DRB4D1D2 (1) . 15 
Backbone chemical shift assignments of DRB4D2D1, DRB4C and DRB4Cc
Unambiguous backbone chemical shift assignments were obtained using standard triple resonance experiments. The backbone chemical shift assignments of DRB4C were achieved using HNCO, HN(C)N and HNN based experiments (3, 4) . Nearly 82% of the backbone chemical shifts for residues 154 to 313 could be assigned. This does not include the structured C-terminal region (DRB4Cc) as the resonances for this region are missing due to the enhanced τ c and associated deleterious relaxation effects induced by the long N-terminal unstructured region. Attempts to assign the backbone chemical shifts of DRB4Cc, using classical as well as non-uniform sampling methods, failed due to its extreme unstable nature suggesting the requirement of a partner protein for its stability.
NMR derived restraints and structure calculation
All NMR spectra were collected at 298K on Bruker Avance II 600MHz or Avance III 700 MHz NMR spectrometer, which are equipped with a triple resonance TCI cryoprobe. Further, simulated curves were generated for conversion of intensity ratios into distances and used as ready reckoner to estimate distances for experimentally derived I para /I dia ratios ( Supplementary   Fig. S12a ). Quality of the PRE restraints was calculated using the following equation (Eq. 3).
Intradomain PREs were used to calibrate the intensities. The distances derived from PRE were estimated using the method described by Rumpel et al. (9) . On an average, it was found that MTSL influenced amide NH crosspeak intensities up to 21 Å. PRE based distance restraints were categorized into three classes. Resonances with intensity ratio above than 0.2 and less than 0.85 (0.2<I para /I dia <0.85),
were restrained to 17 Å with an error set to 4Å. Peaks with intensities above 0.85 were restrained to 90 Å as upper bound distance and 16 Å as the lower bound limit. For resonances with intensity ratio less than 0.2, lower and upper bound distances were set to 2.8 Å and 13 Å, respectively.
Once the individual domain structures were obtained, PREs (six sets: Q8C, A24C, A69C, N85C, A102C and M148C) were included in the structure calculations. Final structures were calculated with the incorporation of all NOEs, dihedral angles, six sets of PREs and refined with RDCs. As errors in PREs were up to 4 Å, categorizing the PRE distances into 3 bins did not greatly affect the calculated structures as described earlier (8) .
N relaxation dispersion
15 N relaxation dispersion experiments were collected on DRB4D1 and DRB4D2 using relaxation compensated CPMG (RC CPMG) scheme (10 
I para
collected over a constant relaxation time of 30 ms. For error analysis, a pair of duplicate and triplicate points were collected for dsRBD1 and dsRBD2, respectively. NMR spectra were processed using NMRPipe, assignments and peak adjustments were carried out using SPARKY (11, 12) . Relaxation dispersion data from both fields were fitted simultaneously to fast limit CPMG function (Eq. 4) using CPMGFit (http://www.palmer.hs.columbia.edu).
(4)
RNA preparation
13 bp RNA (sense: 5ʹ-UGA GGU AGU AGA G UU-3ʹ) and 20 bp RNA (sense: 5ʹ-UGA GGU AGU AGG UUG UAU AG UU-3ʹ) containing 2nt 3ʹ overhang were custom synthesized, desalted, HPLC purified and obtained commercially. 80 bp dsRNA with the sense strand sequence as, 5ʹ-GGG UGC UGU UUC UCG UGU UCG UGU UCG UUU CUCU UCU CUU GUC CUU GUU CUG UUC UCC UUU GUU CGU UCC UGU UCC CCU U-3ʹ was transcribed in vitro using T7 RNA polymerase. In vitro transcribed product was digested with Turbo DNaseI and RNA was purified by phenol chloroform extraction, followed by ethanol precipitation and gel extraction. Prior to dsRNA assays, equimolar concentrations of sense and antisense RNA were annealed in dsRNA buffer (20 mM HEPES (pH 7.2), 50 mM NaCl and 2 mM DTT) by heating at 95°C for 5 min, followed by flash cooling at 4°C. Small angle X-ray scattering (SAXS) and structure modeling SAXS measurements were performed using in-house instrument, S3 Micro (Hecus X-ray systems).
Guanidine Hydrochloride denaturation studies
Scattering was collected on DRB4D1D2 (in 20 mM sodium phosphate buffer (pH 7.4), 100 mM NaCl and 2 mM DTT) with concentrations ranging from 5 mg/mL to 20 mg/mL and samples were kept 300 mm from the Pilatus 100 K detector. Raw data was processed using FIT2D program (13). Radius of gyration (R g ) and D max were calculated from PRIMUS and GNOM (14, 15) . Ten low-resolution ab initio structures were constructed using DAMMIN and averaged using SUPCOMB and DAMAVER (16, 17) .
Analytical ultra centrifugation
Sedimentation velocity (SV) experiment was performed at 40,000 rpm at 20°C on 0.1-1.25 mg/mL concentrations of DRB4C using Beckman Optima XL-I analytical ultracentrifuge. Prior to the measurements, samples were buffer exchanged with 50 mM potassium phosphate buffer (pH 7.2), 100 mM Na 2 SO 4 and 2 mM DTT. Measurements were collected for every 12 min interval using absorbance optics. Sedimentation coefficient S 20,w and molecular weight of the protein was calculated by fitting the non-linear sedimentation boundary profile with Lamm equation (Eq. 5) using SEDFIT package.
The parameters required, like viscosity, partial specific volume, density were obtained from SEDNTERP. 1 H NMR of 13 bp dsRNA representing the imino proton fingerprint region in free state and upon titration with (A) DRB4D1, (B) DRB4D2, and (C) DRB4D1D2. Assigned chemical shifts for the imino protons are annotated above each resonance. The minor shift for U'10 and U6 as well as the resonance annotated with an asterisk in (A) and (C), features that are missing in (B), are primarily due to the different local environment caused by different amino acids in the dsRNA binding region of dsRBD1 over dsRBD2. The dampened intensities for all resonances in the titration data of (C) are due to significantly reduced receiver gain during experimental conditions. Importantly, changes experienced by 13 bp dsRNA upon titration with DRB4D1 and DRB4D1D2 are identical suggesting that DRB4 dsRBD1 is the key dsRNA binding domain. Figure S6 . The imino proton fingerprint region in the free and the bound state of 20 bp dsRNA upon titration with (A) DRB4D1, (B) DRB4D2, and (C) DRB4D1D2. At molar excess concentrations, the imino peaks appear better as they originate from the excess free RNA in the titration mixture. Due to the significant broadening of all imino protons at 1:0.5 molar ratio of protein:dsRNA, the peaks are represented with factor two enhancement. Contrary to the 13 bp dsRNA titration ( Supplementary Fig S5) , majority of the imino protons experience broadening at or below molar equivalence implying that DRB4 dsRBDs recognize longer dsRNA using a different binding mechanism. The free dsRNA spectrum (bottom spectrum in all panels) and all the data in (C) are comparatively better resolved as these were collected at a 700 MHz NMR spectrometer. Table S1C . The isotherm obtained for DRB4D2 is highly identical to Fig  3F suggesting that the DRB4D2:20 bp dsRNA binding mode is independent of the titrant. The fitted isotherm yielded a single-site average binding mode due to the availability of free excess dsRNA in the cell, in contrast to the two-site binding mode obtained for DRB4D1 and DRB4D1D2 earlier when the dsRNA from syringe was titrated with protein in the cell (Fig 3C and 5C ). Supplementary Fig S7A and Supplementary Fig S7C) , whereas majority of the dsRBD2 residues predominantly exhibit chemical shift perturbations (consistent with DRB4D2, Supplementary Fig S7B and  Supplementary Fig S7D) albeit with some broadening. The dsRBD2 also show relatively weaker perturbations as only ~ 30% is able to bind to dsRNA (in corroboration with observation made in Fig.  S6A ). The dsRBDs in DRB4D1D2 retain the longer dsRNA recognition characteristics as exhibited by the individual domains. Collectively, it appears that the broadening exhibited by dsRBD1 is due to multiple bindings (upto four) as well as its ability to slide on long dsRNA whereas dsRBD2 makes transient contacts. As dsRBD2 cannot bind to the same dsRNA that is already occupied with dsRBD1, a complex macromolecular assembly formed by two molecules of dsRNA and DRB4D1D2 is probably causing broadening observed in the 1D NMR of imino protons of 20 bp dsRNA at an equimolar concentration ( Supplementary Fig S6C) . 
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